Clausen, L.N.; Weis, N.; Ladelund, S.; Madsen, L.; Lunding, S.; Tarp, B.; Christensen, P.B.; Krarup, H.B.; Møller, A.; Gerstoft, J.;
et al. Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection. Int. J. Mol. Sci. 2015, 16, 3213-3225.
https://doi.org/10.3390/ijms16023213
AMA Style
Clausen LN, Weis N, Ladelund S, Madsen L, Lunding S, Tarp B, Christensen PB, Krarup HB, Møller A, Gerstoft J,
et al. Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection. International Journal of Molecular Sciences. 2015; 16(2):3213-3225.
https://doi.org/10.3390/ijms16023213
Chicago/Turabian Style
Clausen, Louise Nygaard, Nina Weis, Steen Ladelund, Lone Madsen, Suzanne Lunding, Britta Tarp, Peer Brehm Christensen, Henrik Bygum Krarup, Axel Møller, Jan Gerstoft,
and et al. 2015. "Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection" International Journal of Molecular Sciences 16, no. 2: 3213-3225.
https://doi.org/10.3390/ijms16023213
APA Style
Clausen, L. N., Weis, N., Ladelund, S., Madsen, L., Lunding, S., Tarp, B., Christensen, P. B., Krarup, H. B., Møller, A., Gerstoft, J., Clausen, M. R., Benfield, T., & The DANHEP group.
(2015). Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection. International Journal of Molecular Sciences, 16(2), 3213-3225.
https://doi.org/10.3390/ijms16023213